Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
2(15%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
11
85%
Ph phase_2
1
8%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution12 total trials
Phase 2Efficacy & side effects
1(8.3%)
N/ANon-phased studies
11(91.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

2

trials recruiting

Total Trials

13

all time

Status Distribution
Active(3)
Completed(8)
Terminated(1)
Other(1)

Detailed Status

Completed8
Active, not recruiting1
unknown1
Not yet recruiting1
Recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
2
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (8.3%)
N/A11 (91.7%)

Trials by Status

completed862%
active_not_recruiting18%
unknown18%
not_yet_recruiting18%
recruiting18%
withdrawn18%

Recent Activity

Clinical Trials (13)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
13